Chemotherapy less likely to benefit older patients with breast cancer
the ONA take:
Examining data from Surveillance, Epidemiology and End Results (SEER) database, researchers from The University of Texas Health Science Center at Houston (UTHealth) found that chemotherapy does not improve survival for older women with breast cancer.
SEER database provided information on 14,440 women with stage I to IIIA hormone receptor-negative breast cancer and 26,893 men and women with stage III colon cancer. All diagnoses were made between 1992 and 2009, and all patients were older than 65 years.
Risk of death from all causes decreased by age among the women who had breast cancer (30% for women ages 65 to 69 years; 26% for ages 70 to 74 years; 24% for ages 75 to 79). The risk of mortality was not significantly reduced for women older than 80 years.
However, this trend was not seen among men and women with colon cancer. Chemotherapy remained effective for these patients until age 89 years.
The investigators noted that previous research showed that chemotherapy is inefficient in patients older than 70 years with breast cancer, but the sample sizes were small. The larger sample size used in this study provides strong evidence to support this finding.
Chemotherapy does not improve survival for older women with breast cancer.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|